functional genomics reveal serine synthesis pathway essential breast cancer
cancer cells adapt metabolic processes drive macromolecular biosynthesis rapid cell growth proliferation rna interference rnai-based loss-of-function screening proven powerful identification new interesting cancer targets recent studies used technology vivo identify novel tumour suppressor genes developed method identifying novel cancer targets via negative-selection rnai screening using human breast cancer xenograft model orthotopic site mouse using method screened set metabolic genes associated aggressive breast cancer stemness identify required vivo tumorigenesis among genes identified phosphoglycerate dehydrogenase phgdh genomic region recurrent copy number gain breast cancer phgdh protein levels elevated % oestrogen receptor er-negative breast cancers phgdh catalyses first step serine biosynthesis pathway breast cancer cells high phgdh expression increased serine synthesis flux suppression phgdh cell lines elevated phgdh expression without causes strong decrease cell proliferation reduction serine synthesis find phgdh suppression affect intracellular serine levels causes drop levels alpha-ketoglutarate another output pathway tricarboxylic acid tca cycle intermediate cells high phgdh expression serine synthesis pathway contributes approximately % total anaplerotic flux glutamine tca cycle results reveal certain breast cancers dependent increased serine pathway flux caused phgdh overexpression demonstrate utility vivo negative-selection rnai screens finding potential anticancer targets
